Vitamin D analog shuts down pancreatic cancer's shield in a clinical trial
A small clinical trial led by Dana-Farber Cancer Institute researchers has put a Salk Institute idea to the test in patients: that activating the vitamin D receptor can help reshape the protective environment surrounding ...
17 hours ago
0
65









